Estimating Weight of Patients With Acute Stroke When Dosing for Thrombolysis. Issue 1 (January 2016)
- Record Type:
- Journal Article
- Title:
- Estimating Weight of Patients With Acute Stroke When Dosing for Thrombolysis. Issue 1 (January 2016)
- Main Title:
- Estimating Weight of Patients With Acute Stroke When Dosing for Thrombolysis
- Authors:
- Barrow, Tom
Khan, Muhammad S.
Halse, Omid
Bentley, Paul
Sharma, Pankaj - Abstract:
- Abstract : Background and Purpose—: Estimating patient weight forms an important part of emergency ischemic stroke management guiding the dose of alteplase (tissue-type plasminogen activator). Weighing patients with stroke can be logistically challenging and time consuming, potentially delaying treatment times. We aimed to assess the reliability of approximating weight to determine recombinant tissue-type plasminogen activator dose and whether potential inaccurate dosing affected patient outcomes. Methods—: Two hundred forty-two consecutive patients were studied at a large tertiary stroke center. Estimated and actual measured weight, alteplase dose, and pre-and post-modified Rankin Scale/National Institute of Health Stroke Scale outcome were recorded for each patient. Results—: Clinicians significantly underestimated weights by 1.13 kg (range, −43 to +18 kg; SD, 7.14; P <0.05). The difference between estimated and actual weight proved to be greatest in the heaviest third of patients (−4.51 kg; SD, 8.35; P <0.001), resulting in 19.7% of patients receiving a deviation of at least 10% from the recommended recombinant tissue-type plasminogen activator dose. On average, the heaviest third of patients received an underdose of 0.04 mg/kg and were found to have a greater baseline National Institute of Health Stroke Scale on admission ( P <0.001). National Institute of Health Stroke Scale improvement by day 7 or on discharge was significantly reduced in patients weighing >78 kgAbstract : Background and Purpose—: Estimating patient weight forms an important part of emergency ischemic stroke management guiding the dose of alteplase (tissue-type plasminogen activator). Weighing patients with stroke can be logistically challenging and time consuming, potentially delaying treatment times. We aimed to assess the reliability of approximating weight to determine recombinant tissue-type plasminogen activator dose and whether potential inaccurate dosing affected patient outcomes. Methods—: Two hundred forty-two consecutive patients were studied at a large tertiary stroke center. Estimated and actual measured weight, alteplase dose, and pre-and post-modified Rankin Scale/National Institute of Health Stroke Scale outcome were recorded for each patient. Results—: Clinicians significantly underestimated weights by 1.13 kg (range, −43 to +18 kg; SD, 7.14; P <0.05). The difference between estimated and actual weight proved to be greatest in the heaviest third of patients (−4.51 kg; SD, 8.35; P <0.001), resulting in 19.7% of patients receiving a deviation of at least 10% from the recommended recombinant tissue-type plasminogen activator dose. On average, the heaviest third of patients received an underdose of 0.04 mg/kg and were found to have a greater baseline National Institute of Health Stroke Scale on admission ( P <0.001). National Institute of Health Stroke Scale improvement by day 7 or on discharge was significantly reduced in patients weighing >78 kg (National Institute of Health Stroke Scale score difference of 4.0 points, P <0.05) than in lighter individuals. Conclusions—: Clinicians are poor at approximating the weights of patients with stroke in the acute setting, especially when patients lie at the extremes of weight. Beds capable of weighing patients should be mandated in emergency rooms for patients with acute stroke. Abstract : Supplemental Digital Content is available in the text. … (more)
- Is Part Of:
- Stroke. Volume 47:Issue 1(2016)
- Journal:
- Stroke
- Issue:
- Volume 47:Issue 1(2016)
- Issue Display:
- Volume 47, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 47
- Issue:
- 1
- Issue Sort Value:
- 2016-0047-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2016-01
- Subjects:
- cerebral hemorrhage -- comorbidity -- regression analysis -- stroke -- tissue plasminogen activator
Cerebrovascular disease -- Periodicals
Cerebral circulation -- Periodicals
616.81 - Journal URLs:
- http://ovidsp.tx.ovid.com/sp-3.16.0b/ovidweb.cgi?&S=GJCMFPNHCPDDNANKNCKKCFFBNGMHAA00&Browse=Toc+Children%7cYES%7cS.sh.15204_1441956414_76.15204_1441956414_88.15204_1441956414_96%7c411%7c50 ↗
http://www.stroke.ahajournals.org/ ↗
http://stroke.ahajournals.org/ ↗
http://journals.lww.com ↗
http://www.lww.com/Product/0039-2499 ↗ - DOI:
- 10.1161/STROKEAHA.115.011436 ↗
- Languages:
- English
- ISSNs:
- 0039-2499
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8474.900000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 5183.xml